Pritzker signs ‘Katrina's Law', requiring cops to take guns in domestic violence cases
CHICAGO, Ill. (WTVO) – Gov. JB Pritzker, on Monday, singed House Bill 4144, also known as Karina's Law, which requires local police agencies to confiscate firearms from anyone whose Firearm Owner Identification (FOID) card has been revoked because they have a restraining order against them.
The law is aimed at protecting victims of domestic violence. It is named for Karina Gonzalez, a mother who was granted an order of protection against her husband, Jose Alvarez, weeks before he fatally shot both her and their teenage daughter, Daniela, in July 2023.
Alvarez also shot their son, Manny, who survived and lobbied for the General Assembly to pass the law in his mother's name.
'Protecting victims of domestic violence is a cause that's taking a giant leap forward today,' Pritzker said. 'Karina's law will protect survivors of domestic violence and give them the comfort of knowing their abuser will not have easy access to firearms. We owe it to Karina and Daniela — to Manny — and to all the victims and their families, to continue building all the support and protection that we can.'
The law requires police remove firearms from any whose FOID is revoked within 96 hours of a judge issuing a search warrant, addressing the risks associated with firearms and domestic violence situations.
'Karina's law is a pivotal victory in the fight to protect Illinois' people from gun-related domestic violence. Above all, this bill is a testament to the voices of survivors and advocates who led their leaders toward new solutions,' said Lt. Governor Juliana Stratton. 'Karina and Daniela had dreams and aspirations beyond the violence in their home — their lives mattered, and they should be alive today. I thank every advocate and survivor for baring their hearts to inspire change.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
2 killed after gunman opens fire on car on West Side overnight
CHICAGO — A shooting on the city's West Side overnight left two men dead, police say. According to Chicago police, the deadly shooting unfolded just before midnight in the 100 block of North Laramie Avenue in Austin. Read more: Latest Chicago news and headlines Officers say the victims, a 38-year-old man and another man believed to be between 30 and 50 years of age, were sitting in a car in the area when an unknown individual approached and opened fire on them. Both men suffered gunshot wounds to the head and were taken to the hospital, where they were later pronounced dead. Currently, it is unclear what led to the shooting, and no arrests have been made. Authorities have not yet identified the victims, and an investigation into the deadly shooting is currently underway. LATEST CASES: Missing people in Chicagoland Officers ask anyone with information on the shooting to contact CPD Area Four Detectives at 312-746-8251 or dial 911. Those with information that could help authorities in their investigation can also leave a tip at Tips can be filed anonymously. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
38 minutes ago
- Yahoo
Iran launches overnight missile attack on Israel
TEL AVIV, ISRAEL (Associated Press ) — Israel has warned of more attacks on Iran after Iran's deadly retaliatory missile strikes on Israel overnight and into Saturday. The blistering Israeli attacks on Iran's nuclear program and its armed forces began on Friday. Israel's assault used warplanes, as well as drones smuggled into the country in advance, to assault key facilities and kill top generals and scientists. Iran's U.N. ambassador said 78 people were killed and more than 320 wounded in the attacks. Israel said the barrage was necessary before Iran got any closer to building an atomic weapon. The Israeli attack also threw talks between the United States and Iran over an atomic accord into disarray days before the two sides were set to meet Sunday. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Business Upturn
3 hours ago
- Business Upturn
IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA)
NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting Investors have until July 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Iovance securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Sundaram v. Iovance Biotherapeutics, Inc., et al. , No. 25-cv-04177. Why was Iovance Sued for Securities Fraud? Iovance is a commercial-stage biopharmaceutical company focused on the development of treatments for melanoma and other solid tumor cancers. The Company commercially launched its key melanoma treatment Amtagvi in February 2024. Iovance administers Amtagvi at the Company's authorized treatment centers ('ATCs'). As alleged, Iovance repeatedly touted its ATCs as a driver of demand for Amtagvi. In truth, Iovance's ATCs were experiencing long timelines to begin treating patients with Amtagvi, and ineffective patient identification and patient selection for treatment was causing high patient drop-offs at the ATCs. The Stock Declines as the Truth is Revealed On May 8, 2025, Iovance reported disappointing financial results for 1Q25 and announced it was 'revising full-year 2025 revenue guidance.' The Company blamed 'recent launch dynamics,' including slow 'treatment timelines for new ATCs' and 'the variable pace at which ATCs began treating patients,' which 'differs from center to center.' Iovance also blamed the poor results on high 'patient drop-off' due to inadequate 'patient selection' for treatment. On this news, the price of Iovance stock declined more than 44%, from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025. Click here if you suffered losses: What Can You Do? If you invested in Iovance you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619